Recent Updates
Recently added Catalysts
EBS

Emergent BioSolutions to Participate in Virtual Investor Conferences

Key Takeaway: GAITHERSBURG, Md., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following virtual investor conferences through the end of September 2020: 2020 NYSE Healthc

Full Press Release Details

GAITHERSBURG, Md., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following virtual investor conferences through the end of September 2020:
2020 NYSE Healthcare & Technology Investor Access Day
August 18 – virtual one-on-one meetings only
2020 Three Part Advisors Virtual Midwest IDEAS Investor Conference
August 27 – pre-recorded presentation available beginning at 8:00am eastern
2020 Wells Fargo Virtual Healthcare Conference
September 9 – presentation at 8:00am eastern
Robert W. Baird 2020 Global Healthcare Conference
September 10 – presentation at 2:35pm eastern
Morgan Stanley 18th Annual Global Healthcare Conference 2020
September 14 – presentation at 4:30pm eastern
Cantor Virtual Global Healthcare Conference 2020
September 15 – presentation at 3:20pm eastern
2020 Singular Research Compelling Values Webcall
September 17 – presentation at 12:00pm eastern
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”
About Emergent BioSolutions
Vice President, Investor Relations
Senior Director, Global Communications & Public Affairs

Tags

Emergent Investor Conferences
Investor Conferences
Emergent BioSolutions
Last updated: Aug 18, 2020